UTSW researchers neutralize genetic risk factor found in 50 to 80 percent of human cases
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.
Apolipoprotein E (ApoE) is a protein that carries fatty substances called lipids and cholesterol around the brain and plays an important role in repair mechanisms. There are three major forms of ApoE (i.e., ApoE2, ApoE3, and ApoE4); individuals who carry ApoE4 are up to 10 times more likely to develop Alzheimer’s than those with ApoE2 and ApoE3 forms. ApoE4 promotes accumulation of the b-amyloid protein that causes the characteristic plaques seen in the brains of Alzheimer’s patients.
UT Southwestern molecular biologist and Alzheimer’s expert Dr. Joachim Herz, lead author of the study, which was published in the November issue of eLife said the goal of his team is to prevent the disease from ever manifesting. Late-onset Alzheimer’s generally is diagnosed about age 65 and is the most common cause of dementia in the elderly. “If we can negate the ApoE4 process early, we may be able to prevent late-onset Alzheimer’s altogether for many people so that they will never get sick,” Dr. Herz said.
ApoE4 has been shown to suppress and trap synaptic receptors within intracellular vesicles. However, how the ApoE4 gets trapped has remained a mystery until now. According to Dr. Herz, ApoE4 is the root cause of a “traffic jam” inside the cells that take up ApoE4 and this is associated with reduced recycling of intracellular endosomal transport vesicles. UTSW researchers found that lowering the pH of these endosomes, i.e., by making them more acidic, cleared the traffic jam: The scientists were able to completely reverse the ApoE4-induced recycling block in mice through pharmacological and genetic inhibition of the NHE6 protein, which acts to make the endosomal vesicles less acidic.
These findings suggest a novel potential therapeutic approach for the prevention of late-onset Alzheimer’s disease, Dr. Herz said. The vesicle traffic jam due to the selective loss of solubility of ApoE4 likely is the earliest mechanism at which the protein negatively affects nerve cells, Dr. Herz said.
Most Alzheimer’s research has focused on halting the formation of amyloid and tau protein aggregates once they exist in the brain and degeneration has already begun. “Our approach in this study was to stop the overall degeneration process earlier; that is, before the formation of these aggregates,” Dr. Herz said.
The next step is to develop tailor-made, small molecule inhibitors that can enter the brain efficiently and selectively block NHE6, he added.
“The beauty of NHE inhibitors is that these are small molecules that can be produced inexpensively and thus made widely available, in contrast to the more elaborate antibody-based therapies that are currently being evaluated in clinical trials. A simple pill could someday neutralize the risk of late-onset Alzheimer’s disease just as readily available statins are able to reduce the risk of cardiovascular disease,” Dr. Herz said.
The Latest on: Late-onset Alzheimer’s
via Google News
The Latest on: Late-onset Alzheimer’s
- Classifying Alzheimer's on February 18, 2019 at 1:12 pm
But scientists are starting to get a clearer picture of it. In a new study, researchers looked at more than 4,000 patients with late-onset Alzheimer’s. They placed them in six different groups based o... […]
- Dementia: Understanding makes all the difference on February 9, 2019 at 6:29 am
It’s named after Dr. Alois Alzheimer, who in 1906, “noticed changes in the brain tissue of a woman who had died of an unusual mental illness,” according to the National Institute of Aging. The disease ... […]
- Why Does Alzheimer’s Pose a Greater Risk for Women Than Men? on February 7, 2019 at 3:24 pm
Another important factor is that the APOE4 gene, the strongest genetic risk for late-onset Alzheimer’s, also increases the risk of heart disease. It is possible that the heart disease risk of APOE4 ta... […]
- Warning! Dementia ahead: New research reveals connections between heart conditions, stroke and cognitive decline on February 6, 2019 at 9:01 pm
"The most startling finding is that people with heart conditions have a significantly increased risk of vascular cognitive impairment and possibly dementia ... the risk of late onset vascular ... […]
- Interactions between Apolipoprotein E and Apolipoprotein(a) in Patients with Late-Onset Alzheimer Disease on February 4, 2019 at 2:50 pm
Vincent Mooser, MD; Nicole Helbecque, PhD; Judit Miklossy, MD; Santica M. Marcovina, PhD; Pascal Nicod, MD; Philippe Amouyel, MD, PhD Dr. Marcovina: University of Washington, Northwest Lipid Research ... […]
- In Alzheimer’s, Too Little REST Spurs Too Much Neurogenesis on February 4, 2019 at 1:49 pm
A paper published January 29 in Cell Reports claims that among the earliest changes in sporadic Alzheimer’s disease (SAD ... progenitor cells derived from fibroblasts of patients with late-onset AD ha... […]
- Clues To Cellular Energy Production And Late Onset Alzheimer’s on January 27, 2019 at 5:38 pm
A recent study has revealed energy production within the brain may play a role in development of late onset AD. Disrupted energy production would present severe problems as the brain is the most energ... […]
- Blood test detects Alzheimer's damage before symptoms on January 21, 2019 at 1:58 pm
Protein levels are high in people with Lewy body dementia and Huntington's disease. "It will be important to confirm our findings in late-onset Alzheimer's disease and to define the time period over w... […]
- Researchers define six types of Alzheimer’s disease. Why that matters to you. on December 27, 2018 at 3:03 am
“This is the beginning of a very long process.” The researchers analyzed data on 4,050 people with late-onset dementia from five previous studies. They divided the patients into six groups based on th... […]
- Vaccine or drug for late-onset Alzheimer's could be on the way on December 18, 2018 at 3:32 am
PanARMENIAN.Net - UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer's disease, opening the door to development of a drug that cou... […]
via Bing News